
    
      To evaluate the efficacy and safety of modafinil in reducing methamphetamine use in subjects
      with methamphetamine dependence. It is hypothesized that modafinil, compared to placebo, will
      be associated with an increase in the number of methamphetamine non-use weeks over time as
      measured by quantitative urine analysis for methamphetamine.
    
  